Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 9/20 | 0.68 |
| ▸ | ADRB3 | P13945 | 7/20 | 0.56 |
| ▸ | ADRB1 | P08588 | 6/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | ADRA1A | P35348 | 5/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.53 |
| ▸ | ADRA1D | P25100 | 4/20 | 0.53 |
| ▸ | ADRA1B | P35368 | 4/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.53 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | HTR1A | P08908 | 2/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.53 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12327045 | 0.84 | ADRB2 (0.67) | ADRB2ADRB3ADRB1ALDH1A1MEN1 | |
| SCHEMBL12326921 | 0.84 | ADRB2 (0.67) | ADRB2ADRB3ADRB1ALDH1A1MEN1 | |
| Ractopamine SCHEMBL27826973 | 0.84 | ADRB2 (0.82) | ADRB2ADRB3ADRB1ALDH1A1MEN1 | |
| Acetic Acid SCHEMBL10562052 | 0.84 | ADRB2 (0.78) | ADRB2ADRB3ADRB1ALDH1A1MEN1 | |
| SCHEMBL11480783 | 0.84 | ADRB2 (0.86) | ADRB2ADRB3ADRB1ALDH1A1MEN1 | |
| SCHEMBL10731594 | 0.84 | ADRB2 (0.86) | ADRB2ADRB3ADRB1ALDH1A1MEN1 | |
| SCHEMBL11480791 | 0.84 | ADRB2 (0.86) | ADRB2ADRB3ADRB1ALDH1A1MEN1 | |
| SCHEMBL9006822 | 0.84 | ADRB2 (0.86) | ADRB2ADRB3ADRB1ALDH1A1MEN1 | |
| SCHEMBL9006836 | 0.84 | ADRB2 (0.86) | ADRB2ADRB3ADRB1ALDH1A1MEN1 | |
| SCHEMBL9006843 | 0.84 | ADRB2 (0.86) | ADRB2ADRB3ADRB1ALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8383685-B2 | Use of RR/SR-ractopamine | BRIDGE PHARMA, INC. (US) | 2013-02-26 | — | — | US | disclosed |
| US-20120015895-A1 | Use Of RR/SR-Ractopamine | BRIDGE PHARMA, INC. (US) | 2012-01-19 | — | — | US | disclosed |
| US-8071653-B2 | Use of RR/SR-ractopamine | BRIDGE PHARMA, INC. (US) | 2011-12-06 | — | — | US | disclosed |
| US-20100184865-A1 | Use Of RR/SR-Ractopamine | BRIDGE PHARMA, INC. (US) | 2010-07-22 | — | — | US | disclosed |
| US-7723392-B2 | Use of RR/SR-ractopamine | BRIDGE PHARMA, INC. (US) | 2010-05-25 | — | — | US | disclosed |
| WO-2009073051-A1 | USE OF RR/SR-RACTOPAMINE | BRIDGE PHARMA, INC. (US) | 2009-06-11 | — | — | WO | disclosed |
| US-20090143480-A1 | Use of RR/SR-ractopamine | BRIDGE PHARMA, INC. | 2009-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120015895-A1 | Use Of RR/SR-Ractopamine | SRR, SRRM2, MTPN | ADRB2 19/4885ADRB3 12/4885ADRB1 7/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.